Torsade de pointes associated with chloroquine, hydroxychloroquine, and azithromycin: a retrospective analysis of individual case safety reports from VigiBase.

Diego Macías Saint-GeronsRafael Tabarés-Seisdedos

Published in: European journal of clinical pharmacology (2021)

The prescription of CQ, HCQ, and AZT should be restricted to therapeutic indications with established positive benefit/risk profile. Doctors and patients should be aware of this potential adverse reaction especially when several risk factors are present.

Keyphrases

risk factors
end stage renal disease
ejection fraction
chronic kidney disease
prognostic factors
risk assessment
drug induced
climate change